GlassScriptPhysician profile
Zalman Levine
NPI 1245335652
$795.65
in general payments reported to CMS, 2019-2025
7 companies · $33.06 in 2025
The $33.06 reported for 2025 was less than what a typical Reproductive Endocrinology provider received nationally (typical 2025 total: $140).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $172 · 2020: $56.44 · 2021: $212 · 2022: $88.39 · 2023: $152 · 2024: $82.49 · 2025: $33.06.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $267.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $267.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $508.92 | 2019-2025 | Menopur |
| Coopersurgical, INC. | $111.90 | 2021-2023 | Stripper |
| Emd Serono, INC. | $109.06 | 2019-2023 | |
| Merck Sharp & Dohme LLC | $24.61 | 2021 | |
| Duchesnay USA Incorporated | $14.38 | 2019 | |
| Exeltis, USA INC. | $13.63 | 2019 | |
| Avion Pharmaceuticals | $13.15 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Zalman Levine listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.